2m 2m 2m 2m 2m 2m 2m
ROIVANT SCIENCES (ROIV)
NASDAQ
$32.17+$0.91 (+2.93%)
Price as of Jun 23, 2026 6:50 PM EDT- $22.3BMarket Cap
- 171.74%1-Year Change
- BiotechnologyIndustry
ROIVANT SCIENCES (ROIV)
$32.17+$0.91 (+2.93%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 10.84% | 78.0M | +12.2M (+15.65%) | Mar 31, 2026 |
MORGAN STANLEY | 7.21% | 51.8M | -6.5M (-12.60%) | Mar 31, 2026 |
BLACKROCK, INC. | 6.15% | 44.3M | +3.1M (+6.97%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 5.86% | 42.2M | +195,472 (+0.46%) | Dec 31, 2024 |
VANGUARD GROUP INC | 5.85% | 42.1M | +3.3M (+7.74%) | Dec 31, 2025 |
BLACKROCK INC. | 4.92% | 35.4M | -817,249 (-2.31%) | Jun 30, 2024 |
QVT FINANCIAL LP | 3.50% | 25.2M | -1.2M (-4.87%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 5.08% | 36.6M | +1.4M (+3.87%) | Mar 31, 2026 |
FIDELITY MT VERNON STREET TRUST | 2.41% | 17.4M | 0 (0.00%) | Feb 28, 2026 |
VANGUARD SPECIALIZED FUNDS | 1.33% | 9.6M | 0 (0.00%) | Jan 31, 2026 |
SPDR SERIES TRUST | 1.14% | 8.2M | 0 (0.00%) | Jan 31, 2026 |
T. Rowe Price Mid-Cap Growth Fund, Inc. | 0.73% | 5.3M | 0 (0.00%) | Mar 31, 2026 |
MORGAN STANLEY INSTITUTIONAL FUND INC | 0.66% | 4.8M | 0 (0.00%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 0.64% | 4.6M | 0 (0.00%) | Feb 28, 2026 |
Current Ownership Distribution
- Institutions8.7B (86.15%)
- Mutual Funds771.5M (7.67%)
- Insiders621.2M (6.18%)
- Other0 (0.00%)
Insider Transactions
- 6.18% (621.2M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 11Number of InsiderSelling (last 12 months)
- $15.9BAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Humes Jennifer Chief Accounting Officer | Sell | Apr 08, 2026 | $384,073.06 | 13,538 | $28.37 | 84,191 |
Sukhatme Mayukh President & CIO | In Kind | Mar 31, 2026 | $5.2M | 187,512 | $27.70 | 18.7M |
Torti Frank President and Vant Chair | In Kind | Mar 31, 2026 | $4.4M | 160,035 | $27.70 | 13.6M |
Gline Matthew CEO | In Kind | Mar 31, 2026 | $8.4M | 304,684 | $27.70 | 17.0M |
Sukhatme Mayukh President & CIO | Exempt | Mar 30, 2026 | $15.0M | 1.3M | $11.50 | 0 |
Gline Matthew CEO | Exempt | Mar 30, 2026 | $25.0M | 2.2M | $11.50 | 0 |
Sukhatme Mayukh President & CIO | Exempt | Mar 30, 2026 | $0.00 | 58,391 | $0.00 | 18.9M |
Gline Matthew CEO | Exempt | Mar 30, 2026 | $0.00 | 97,319 | $0.00 | 17.4M |
Sukhatme Mayukh President & CIO | In Kind | Mar 30, 2026 | $787,255.69 | 29,809 | $26.41 | 18.9M |
Gline Matthew CEO | In Kind | Mar 30, 2026 | $1.4M | 53,826 | $26.41 | 17.3M |
Fitzgerald Meghan | Exempt | Mar 26, 2026 | $0.00 | 70,000 | $0.00 | 48,578 |
Fitzgerald Meghan | Exempt | Mar 26, 2026 | $616,000.00 | 70,000 | $8.80 | 112,963 |
Fitzgerald Meghan | Sell | Mar 26, 2026 | $1.9M | 70,000 | $27.45 | 42,963 |
Pulik Richard CFO | In Kind | Mar 20, 2026 | $42,824.20 | 1,546 | $27.70 | 236,867 |
Humes Jennifer Chief Accounting Officer | In Kind | Mar 20, 2026 | $402,370.20 | 14,526 | $27.70 | 97,729 |
Epperly Melissa B, | Sell | Mar 16, 2026 | $1.2M | 41,861 | $28.68 | 15,804 |
Torti Frank President and Vant Chair | Exempt | Feb 23, 2026 | $2.3M | 587,390 | $3.85 | 14.3M |
Torti Frank President and Vant Chair | Sell | Feb 23, 2026 | $16.2M | 587,390 | $27.51 | 13.7M |
Torti Frank President and Vant Chair | Exempt | Feb 23, 2026 | $0.00 | 587,390 | $0.00 | 3.0M |
Venker Eric President & Immunovant CEO | In Kind | Feb 20, 2026 | $191,434.65 | 7,051 | $27.15 | 1.6M |
Pulik Richard CFO | In Kind | Feb 20, 2026 | $27,150.00 | 1,000 | $27.15 | 238,413 |
Torti Frank President and Vant Chair | Exempt | Feb 20, 2026 | $3.9M | 1.0M | $3.85 | 14.7M |
Torti Frank President and Vant Chair | Sell | Feb 20, 2026 | $27.5M | 1.0M | $27.15 | 13.7M |
Torti Frank President and Vant Chair | Exempt | Feb 20, 2026 | $0.00 | 1.0M | $0.00 | 3.6M |
Torti Frank President and Vant Chair | Exempt | Feb 19, 2026 | $0.00 | 1.4M | $0.00 | 4.6M |
Torti Frank President and Vant Chair | Exempt | Feb 19, 2026 | $5.4M | 1.4M | $3.85 | 15.1M |
Torti Frank President and Vant Chair | Sell | Feb 19, 2026 | $38.4M | 1.4M | $27.42 | 13.7M |
Gold Daniel Allen | Sell | Feb 13, 2026 | $4.0M | 150,784 | $26.49 | 15.4M |
Venker Eric President & Immunovant CEO | Exempt | Feb 13, 2026 | $0.00 | 200,000 | $0.00 | 5.0M |
Gold Daniel Allen | Sell | Feb 13, 2026 | $6.0M | 225,000 | $26.50 | 15.1M |